Reversal of Cardiac Dysfunction After Long-Term Expression of SERCA2a by Gene Transfer in a Pre-Clinical Model of Heart Failure - Université d'Angers Accéder directement au contenu
Article Dans Une Revue Journal of the American College of Cardiology Année : 2008

Reversal of Cardiac Dysfunction After Long-Term Expression of SERCA2a by Gene Transfer in a Pre-Clinical Model of Heart Failure

Yoshiaki Kawase
  • Fonction : Auteur
Hung Ly
  • Fonction : Auteur
Fabrice Prunier
  • Fonction : Auteur
  • PersonId : 992121
Djamel Lebeche
  • Fonction : Auteur
Yanfen Shi
  • Fonction : Auteur
Hongwei Jin
  • Fonction : Auteur
Lahouaria Hadri
  • Fonction : Auteur
Ryuichi Yoneyama
  • Fonction : Auteur
Kozo Hoshino
  • Fonction : Auteur
Yoshiaki Takewa
  • Fonction : Auteur
Susumu Sakata
  • Fonction : Auteur
Richard Peluso
  • Fonction : Auteur
Krisztina Zsebo
  • Fonction : Auteur
Judith Gwathmey
  • Fonction : Auteur
Jean-Claude Tardif
  • Fonction : Auteur
Jean-François Tanguay
  • Fonction : Auteur
Roger Hajjar
  • Fonction : Auteur

Résumé

Objectives The aim of this study was to examine the effects of sarcoplasmic reticulum Ca2+ ATPase (SERCA2a) gene transfer in a swine heart failure (HF) model.Background Reduced expression and activity of SERCA2a have been documented in HF. Prior studies have reported the beneficial effects of short-term SERCA2a overexpression in rodent models. However, the effects of long-term expression of SERCA2a in pre-clinical large animal models are not known. Methods Yorkshire-Landrace pigs were used (n = 16) to create volume overload by percutaneously severing chordae tendinae of the mitral apparatus with a bioptome to induce mitral regurgitation. At 2 months, pigs underwent intracoronary delivery of either recombinant adeno-associated virus type 1 (rAAV1) carrying SERCA2a under a cytomegalovirus promoter (rAAV1.SERCA2a) (n = 10; group 1) or saline (n = 6; group 2). Results At 2 months, study animals were found to be in a compensated state of volume-overload HF (increased left ventricular internal diastolic and systolic diameters [LVIDd and LVIDs]). At 4 months, gene transfer resulted in: 1) positive left ventricular (LV) inotropic effects (adjusted peak left ventricular pressure rate of rise (dP/dt)max/P, 21.2 ± 3.2 s−1 group 1 vs. 15.5 ± 3.0 s−1 group 2; p < 0.01); 2) improvement in LV remodeling (% change in LVIDs −3.0 ± 10% vs. +15 ± 11%, respectively; p < 0.01). At follow-up, brain natriuretic peptide levels remained stable in group 1 after gene transfer, in contrast to rising levels in group 2. Further, cardiac SERCA2a expression was significantly decreased in group 2 whereas in group 1 it was restored to normal levels. There was no histopathological evidence of acute myocardial inflammation or necrosis. Conclusions Using a large-animal, volume-overload model of HF, we report that long-term overexpression of SERCA2a by in vivo rAAV1-mediated intracoronary gene transfer preserved systolic function, potentially prevented diastolic dysfunction, and improved ventricular remodeling.

Dates et versions

hal-03405228 , version 1 (27-10-2021)

Identifiants

Citer

Yoshiaki Kawase, Hung Ly, Fabrice Prunier, Djamel Lebeche, Yanfen Shi, et al.. Reversal of Cardiac Dysfunction After Long-Term Expression of SERCA2a by Gene Transfer in a Pre-Clinical Model of Heart Failure. Journal of the American College of Cardiology, 2008, 51 (11), pp.1112 - 1119. ⟨10.1016/j.jacc.2007.12.014⟩. ⟨hal-03405228⟩

Collections

UNIV-ANGERS
3 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More